Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

605116.SS Net Margin

The Net Margin of Aurisco Pharmaceutical Co Ltd (605116.SS) is 22.92%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

605116.SS Net Margin - Historical Value
Date Value
2023-12-31 22.92%
2022-12-31 20.92%
2021-12-31 21.00%
2020-12-31 21.79%
2019-12-31 32.00%
2018-12-31 23.77%
2017-12-31 8.21%
605116.SS Net Margin - Peers Comparison
Ticker Name Value
603079.SS Zhejiang Shengda Bio-Pharm Co Ltd -7.43%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 24.25%
688098.SS Shanghai Shen Lian Biomedical Corp 10.45%
688356.SS Jenkem Technology Co Ltd 39.62%
603676.SS Tibet Weixinkang Medicine Co Ltd 18.93%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 20.28%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 9.90%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 17.48%
603538.SS Ningbo Menovo Pharmaceutical Co Ltd 4.87%
002118.SZ Jilin Zixin Pharmaceutical Industrial Co Ltd -828.71%
300573.SZ Shenyang Xingqi Pharmaceutical Co Ltd 17.40%
300636.SZ Jiangxi Synergy Pharmaceutical Co Ltd 14.04%
300871.SZ Wuhan Hvsen Biotechnology Co Ltd 1.65%
603222.SS Chimin Health Management Co Ltd -7.70%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 16.35%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 19.70%
300401.SZ Zhejiang Garden Biopharmaceutical Co Ltd 24.87%
600381.SS Qinghai Spring Medicinal Resources Technology Co Ltd -125.24%
603439.SS Guizhou Sanli Pharmaceutical Co Ltd 17.90%
002644.SZ Lanzhou Foci Pharmaceutical Co Ltd 5.78%
600851.SS Shanghai Haixin Group Co Ltd 18.97%
603566.SS Pulike Biological Engineering Inc 8.90%
300199.SZ Hybio Pharmaceutical Co Ltd -29.42%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd -35.41%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 0.50%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 6.46%
300878.SZ Zhejiang Wecome Pharmaceutical Co Ltd -1.55%
688566.SS Jiangsu Jibeier Pharmaceutical Co Ltd 24.46%